Workup for Bradycardia
The workup for bradycardia should begin with a 12-lead ECG to characterize the rhythm disturbance, followed by cardiac rhythm monitoring (Holter, event monitor, or implantable loop recorder depending on symptom frequency) to establish symptom-rhythm correlation, which is the cornerstone of evaluation 1.
Initial Diagnostic Approach
The fundamental goal is to correlate bradycardia with symptoms rather than treating an arbitrary heart rate cutoff 2. Your workup strategy should be algorithmically determined by symptom frequency:
ECG and Rhythm Monitoring Strategy
12-lead ECG first: Identifies the type of bradycardia (sinus node dysfunction, AV block, conduction disorders) and may reveal acute causes like ischemia or hyperkalemia 1, 3
For daily symptoms: Use 24-48 hour Holter monitoring 1
For weekly symptoms: External loop recorder (patient or auto-triggered) for 2-6 weeks 1
For infrequent symptoms: Implantable loop recorder for months of monitoring 1
For exercise-related symptoms: Exercise ECG testing is reasonable to diagnose chronotropic incompetence or exercise-induced conduction disorders 1
Critical "Cannot-Miss" Causes to Evaluate
Before attributing bradycardia to intrinsic conduction disease, systematically exclude reversible and life-threatening causes 3:
- Hyperkalemia (check basic metabolic panel immediately)
- Myocardial ischemia/infarction (troponin, ECG for ST changes, consider coronary evaluation—bradycardia may resolve with revascularization) 4
- Medication toxicity (beta-blockers, calcium channel blockers, digoxin, antiarrhythmics) 5
- Hypothyroidism (TSH)
- Hypoxia (oxygen saturation, arterial blood gas if indicated)
- Increased intracranial pressure (if neurologic symptoms present) 3
Additional Diagnostic Testing
Based on clinical context:
Echocardiography: Assess for structural heart disease, particularly if congenital heart disease suspected or heart failure symptoms present 6
Electrophysiologic study: Reserved for cases where diagnosis remains unclear after non-invasive testing, or when determining the level of AV block (particularly 2:1 block) 1
Tilt table testing: Consider if neurocardiogenic syncope suspected 6
Key Clinical Pitfalls
Do not rush to permanent pacemaker implantation without establishing symptom-rhythm correlation and excluding reversible causes 6. The 2018 ACC/AHA/HRS guidelines shifted emphasis away from device-based recommendations toward comprehensive evaluation of underlying disease states 2.
Exercise testing rarely uncovers occult conduction disorders (0.45% yield in one series), but when exercise-induced conduction abnormalities occur with ischemia, they typically indicate significant left anterior descending artery stenosis 1. This underscores the importance of CAD evaluation before attributing bradycardia to intrinsic conduction disease 4.
For syncope without exercise-related symptoms, exercise testing has low yield even with imaging 1.
Severity Assessment
Treatment urgency depends on hemodynamic stability and symptom severity, not heart rate alone 6, 2. Indications for intervention include:
- Symptomatic bradycardia (dizziness, confusion, fatigue, syncope)
- Heart failure attributable to bradycardia
- Risk of pause-dependent tachyarrhythmias 5
In critically ill patients, temporary pacing may be needed while addressing underlying causes (drug toxicity, electrolyte abnormalities, post-cardiac surgery) 5.